Patents by Inventor Quinn S. Wells

Quinn S. Wells has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure
    Patent number: 11079394
    Abstract: Methods for detecting angiopoietin-2 (Angpt-2) and/or thrombospondin-2 (Tsp-2) in a sample involve obtaining or having obtained a blood or plasma sample from a subject; and detecting Angpt-2 and Tsp-2 in the sample. Detecting can involve performing an assay to determine whether the sample includes Angpt-2 and/or Tsp-2 or elevated levels of Angpt-2 and/or Tsp-2. Elevated levels are indicative of acute heart failure.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: August 3, 2021
    Assignees: Vanderbilt University, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Thomas J. Wang, Deepak K. Gupta, Quinn S. Wells, Robert E. Gerszten
  • DETECTION OF ANGIOPOIETIN-2 AND THROMBOSPONDIN-2 IN CONNECTION WITH DIAGNOSING ACUTE HEART FAILURE
    Publication number: 20190033323
    Abstract: Methods for detecting angiopoietin-2 (Angpt-2) and/or thrombospondin-2 (Tsp-2) in a sample involve obtaining or having obtained a blood or plasma sample from a subject; and detecting or Angpt-2 and Tsp-2 in the sample. Detecting can involve performing an assay to determine whether the sample includes Angpt-2 and/or Tsp-2 or elevated levels of Angpt-2 and/or Tsp-2. Elevated levels are indicative of acute heart failure.
    Type: Application
    Filed: July 25, 2018
    Publication date: January 31, 2019
    Inventors: Thomas J. Wang, Deepak K. Gupta, Quinn S. Wells, Robert E. Gerszten